Thyroid hormone has a pivotal role in metabolic changes of the bone in Graves’ disease patients because it stimulates both osteoclast [5] and osteoblast [6] activities, with the net effect being the negative regulation of bone mass [7–9]. The gene discussed is TG; the disease is Graves disease.